TB Archives – Page 45 of 49 – Treatment Action Group

2011 Pipeline Report shows that medical prospects for people with HIV, hepatitis C, and tuberculosis have never been better

July 15, 2011
Chad Cipiti

The new drug, diagnostic, and vaccine pipeline has never looked more promising for people with HIV, hepatitis C virus (HCV), and tuberculosis (TB), according to a report released today by Treatment Action Group (TAG) and HIV i-Base.

Poor progress means multidrug-resistant tuberculosis continues to spread and cost lives

July 7, 2011
Chad Cipiti

The global response to help countries scale up treatment of multidrug-resistant tuberculosis (MDR-TB) is underfunded and ineffective, according to a new report released today by three medical and medical advocacy organisations. A 20-month effort to reform the Green Light Committee Initiative, a World Health Organization (WHO)-hosted programme designed to help countries gain technical support for scale up of MDR-TB and access to quality-assured MDR-TB drugs, needs to be closely monitored to see if the reforms will address many key bottlenecks.

Letter to Secretary Clinton on the Global Fund to Fight AIDS, TB, and Malaria

February 7, 2011
Chad Cipiti

February 7, 2011 Dear Secretary Clinton, We write to ask for your leadership in ensuring The Global Fund to Fight AIDS, TB, and Malaria is “open for new business,” saving lives through expanding programming in 2012. We ask that you…

Treatment Action Group Applauds World Health Organization Endorsement of Rapid TB Test That Could Revolutionize Treatment of Tuberculosis

December 8, 2010
Chad Cipiti

A new rapid test for tuberculosis (TB) which was just recommended by the World Health Organization (WHO) for widespread use has the potential to revolutionize the world’s fight against the disease, said the Treatment Action Group today,

TAGline 2010

November 23, 2010
Chad Cipiti

The Fall, Summer, and Winter 2010 issues of TAGline.

Time for a Bold New Vision at the Stop TB Partnership

October 16, 2010
Chad Cipiti

From The Lancet, Volume 376, Issue 9749, Pages 1283 - 1284, 16 October 2010 Salmaan Keshavjee,a,b,c Francoise Girard,d Mark Harrington,e Paul E Farmera,b,c Tuberculosis—a curable infectious disease—continues to cause illness in more than 9 million people annually. In the past…

2010 Pipeline Report

September 3, 2010
Chad Cipiti

HIV, Tuberculosis, and Viral Hepatitis: Drugs, diagnostics, Vaccines, Immune-based therapies, and Preventive Technologies in Development. By Polly Clayden, Lei Chou, Simon Collins, Mark Harrington, Richard Jefferys, Eleonora Jimenez, Scott Morgan, Tracy Swan, Javid Syed and Claire Wingfield.

2009 Report on TB Research Funding Trends

March 25, 2010
Chad Cipiti

2009 TB Research Funding Trends, 2005 - 2008 - Second Edition March 2010 - This is an update to Treatment Action Group’s 2009 report on funding trends for tuberculosis (TB) research and development (R&D) from the baseline year 2005 through…

Monitoring TB/HIV Indicators for UNGASS: Kenya, Uganda and Zambia

January 11, 2010
Chad Cipiti

January 2010 - Despite being curable, Tuberculosis (TB) continues to be the leading cause of death among people with HIV in 2008, accounting for 25% of all HIV-related deaths. The World Health Organization (WHO) has developed a 12-point policy package…

Empowering Communities for TB Advocacy: The TAG-ICW Model

December 2, 2009
Chad Cipiti

2009 This publication by TAG and the International Community of Women Living with HIV–Eastern Africa (ICW) provides activists, policy makers, and donors with lessons learned from two years of capacity building for HIV treatment activists to integrate tuberculosis (TB) and…